Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002

Pediatric Infectious Disease Journal

Volumn 25, Issue 6, 2006, Pages 489-493

  Charles, Myrna D ^a,c   Holman, Robert C ^b   Curns, Aaron T ^b   Parashar, Umesh D ^a   Glass, Roger I ^a   Bresee, Joseph S ^a,d  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c New York City Department of Health   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Gastroenteritis; Hospitalizations; Rotavirus; United States

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RATE; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RNA VIRUS INFECTION; ROTAVIRUS; SEASONAL VARIATION; UNITED STATES; WINTER;

EID: 33744974024     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000215234.91997.21     Document Type: Article

References (25)

1. Parashar UD, Holman RC, Clarke MJ, Bresee JS, Glass RI. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis. 1997;177:13-17.
2. Jin S, Kilgore PE, Holman RC, Clarke MJ, Gangarosa EJ, Glass RI, Trends in hospitalizations for diarrhea in United States children from 1979-1992: Estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J. 1996;15:397-404.
3. Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 1998;279:1371-1376.
4. Centers for Disease Control and Prevention. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. MMWR Morb Mortal Wkly Rep. 1999;48:1-20.
5. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortaly Wkly Rep. 1999;48:1007.
6. Vesikari T, Matson D, Dennehy P, et al. Protection against rotavirus gastroenteritis of multiple serotypes by a pentavalent (human-bovine) reassortant vaccine (PRV). ESPID 2005; Valencia, Spain.
7. Vesikari T, Matson D, Van Damme P, et al. Incidence of intussusception with the pentavalent (human-bovine) reassortant rotaviras vaccine (PRV) is similar to placebo. ESPID 2005; Valencia, Spain.
8. DeVos B, Vesikari T, Linhares AC, et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J. 2004;10:S179-S182.
9. Staat MA, Azimi P, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J. 2002;21:221-227.
10. O'Ryan M, Perez-Schael I, Mamani N, et al. Rotavirus-associated medical visits and hospitalizations in South America: a prospective study at three large sentinel hospitals. Pediatr Infect Dis J. 2001;20:685-693.
11. Bresee J, Fang Z-Y, Wang B, et al. Rotavirus surveillance in Asia: First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis. 2004;10:988-995.
12. Bresee JS, Hummelman EG, Nelson EA, Glass RI. Rotavirus in Asia: The value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis. 2005;192:S1-5.
13. Brandt CD, Kim HW, Rodriguez JO, et al. Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol. 1983;18:71-78.
14. Ho M-S, Glass RI, Pinsky PF, Anderson LJ. Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J Infect Dis. 1988;158:1112-1116.
15. Centers for Disease Control and Prevention. National Hospital Discharge Survey. Multi-Year Data Tape Information 1979-2002. National Center for Health Statistics; 2004.
16. Public Health Service and Health Care Financial Administration. International Classification of Diseases. 9th revision, Clinical modification, 6th ed. (CD-ROM). Public Health Service; 1998.
17. SUDAAN User's Manual. Release 8.0. Research Triangle Park, NC: Research Triangle Institute; 2001.
18. Natality. US Department of Health and Human Services, detailed data 1979-2002. Public use data tape documentation. Centers for Disease Control and Prevention NCfHS; 2003.
19. Intercensal Estimates of the Population of States by Age, Sex, and Race: 1970-2002. Bureau of Census; 2004.
20. Hsu VP, Staat MA, Roberts N, et al. Use of active surveillance to validate ICD code estimates of rotavirus hospitalizations in children. Pediatrics. 2004;115:78-82.
21. Kilgore PE, Holman RC, Clarke MJ, Glass RI. Trends of diarrheal disease-associated mortality in US children, 1968 through 1991. JAMA. 1995;274:1143-1148.
22. Parashar UD, Holman RC, Bresee JS, et al. Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Pediatr Infect Dis J. 1998;17:605-611.
23. Parashar UD, Chung MA, Holman RC, Ryder RW, Hadler JL, Glass RI. Use of state hospital discharge data to assess the morbidity from rotavirus diarrhea and to monitor the impact of a rotavirus immunization program: A pilot study in Connecticut. Pediatrics. 1999;104:489-494.
24. Steele AD, Peenze I, de Beer MC, et al. Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa. Vaccine. 2003;21:354-360.
25. Chang HG, Glass RI, Smith PF, Cicirello HG, Holman RC, Morse DL. Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J. 2003;22:808-14.